GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fukuda Denshi Co Ltd (TSE:6960) » Definitions » Gross Margin %

Fukuda Denshi Co (TSE:6960) Gross Margin % : 51.71% (As of Dec. 2023)


View and export this data going back to 1982. Start your Free Trial

What is Fukuda Denshi Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Fukuda Denshi Co's Gross Profit for the three months ended in Dec. 2023 was 円16,919 Mil. Fukuda Denshi Co's Revenue for the three months ended in Dec. 2023 was 円32,717 Mil. Therefore, Fukuda Denshi Co's Gross Margin % for the quarter that ended in Dec. 2023 was 51.71%.


The historical rank and industry rank for Fukuda Denshi Co's Gross Margin % or its related term are showing as below:

TSE:6960' s Gross Margin % Range Over the Past 10 Years
Min: 40.13   Med: 41.89   Max: 53.61
Current: 53.61


During the past 13 years, the highest Gross Margin % of Fukuda Denshi Co was 53.61%. The lowest was 40.13%. And the median was 41.89%.

TSE:6960's Gross Margin % is ranked better than
50.63% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 53.295 vs TSE:6960: 53.61

Fukuda Denshi Co had a gross margin of 51.71% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Fukuda Denshi Co was 6.10% per year.


Fukuda Denshi Co Gross Margin % Historical Data

The historical data trend for Fukuda Denshi Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fukuda Denshi Co Gross Margin % Chart

Fukuda Denshi Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.13 40.61 42.31 51.16 52.29

Fukuda Denshi Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.26 51.88 56.09 55.24 51.71

Competitive Comparison of Fukuda Denshi Co's Gross Margin %

For the Medical Devices subindustry, Fukuda Denshi Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fukuda Denshi Co's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fukuda Denshi Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Fukuda Denshi Co's Gross Margin % falls into.



Fukuda Denshi Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Fukuda Denshi Co's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )=Gross Profit (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=70403 / 134648
=(Revenue - Cost of Goods Sold) / Revenue
=(134648 - 64245) / 134648
=52.29 %

Fukuda Denshi Co's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=16919 / 32717
=(Revenue - Cost of Goods Sold) / Revenue
=(32717 - 15798) / 32717
=51.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Fukuda Denshi Co  (TSE:6960) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Fukuda Denshi Co had a gross margin of 51.71% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Fukuda Denshi Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of Fukuda Denshi Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fukuda Denshi Co (TSE:6960) Business Description

Traded in Other Exchanges
N/A
Address
39-4, Hongo 3-chome, Bunkyo-ku, Tokyo, JPN, 113-8483
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.

Fukuda Denshi Co (TSE:6960) Headlines

No Headlines